Skip to search.
 FTSE 100 Up 1.02%

More On GS7.F

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GS7.F)

-Frankfurt Ticker: 925288/ISIN: GB0009252882
19.34 Down 0.08(0.42%) 29 Sep 15:43
Prev Close:19.42
Open:19.41
Bid:19.05 x 110000
Ask:19.39 x 110000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:19.34 - 19.52
52wk Range:16.92 - 20.57
Volume:1,632
Avg Vol (3m):5,775
Market Cap:92.66b
P/E (ttm):2,417.38
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback